Literature DB >> 26320949

Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons.

Consiglia Pacelli1, Nicolas Giguère1, Marie-Josée Bourque1, Martin Lévesque2, Ruth S Slack3, Louis-Éric Trudeau4.   

Abstract

Although the mechanisms underlying the loss of neurons in Parkinson's disease are not well understood, impaired mitochondrial function and pathological protein aggregation are suspected as playing a major role. Why DA (dopamine) neurons and a select small subset of brain nuclei are particularly vulnerable to such ubiquitous cellular dysfunctions is presently one of the key unanswered questions in Parkinson's disease research. One intriguing hypothesis is that their heightened vulnerability is a consequence of their elevated bioenergetic requirements. Here, we show for the first time that vulnerable nigral DA neurons differ from less vulnerable DA neurons such as those of the VTA (ventral tegmental area) by having a higher basal rate of mitochondrial OXPHOS (oxidative phosphorylation), a smaller reserve capacity, a higher density of axonal mitochondria, an elevated level of basal oxidative stress, and a considerably more complex axonal arborization. Furthermore, we demonstrate that reducing axonal arborization by acting on axon guidance pathways with Semaphorin 7A reduces in parallel the basal rate of mitochondrial OXPHOS and the vulnerability of nigral DA neurons to the neurotoxic agents MPP(+) (1-methyl-4-phenylpyridinium) and rotenone. Blocking L-type calcium channels with isradipine was protective against MPP(+) but not rotenone. Our data provide the most direct demonstration to date in favor of the hypothesis that the heightened vulnerability of nigral DA neurons in Parkinson's disease is directly due to their particular bioenergetic and morphological characteristics.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26320949     DOI: 10.1016/j.cub.2015.07.050

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  157 in total

Review 1.  Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.

Authors:  Maria Nguyen; Yvette C Wong; Daniel Ysselstein; Alex Severino; Dimitri Krainc
Journal:  Trends Neurosci       Date:  2018-11-30       Impact factor: 13.837

2.  Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons.

Authors:  Nicolas Giguère; Consiglia Pacelli; Caroline Saumure; Marie-Josée Bourque; Diana Matheoud; Daniel Levesque; Ruth S Slack; David S Park; Louis-Éric Trudeau
Journal:  J Biol Chem       Date:  2018-04-26       Impact factor: 5.157

3.  Regional Heterogeneity of D2-Receptor Signaling in the Dorsal Striatum and Nucleus Accumbens.

Authors:  Pamela F Marcott; Sheng Gong; Prashant Donthamsetti; Steven G Grinnell; Melissa N Nelson; Amy H Newman; Lutz Birnbaumer; Kirill A Martemyanov; Jonathan A Javitch; Christopher P Ford
Journal:  Neuron       Date:  2018-04-12       Impact factor: 17.173

Review 4.  The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease.

Authors:  Lena F Burbulla; Dimitri Krainc
Journal:  Neurobiol Dis       Date:  2019-07-25       Impact factor: 5.996

5.  The mitochondrial metabolic function of DJ-1 is modulated by 14-3-3β.

Authors:  Maria Weinert; Aurelie Millet; Elizabeth A Jonas; Kambiz N Alavian
Journal:  FASEB J       Date:  2019-04-29       Impact factor: 5.191

6.  Rare Disease Mechanisms Identified by Genealogical Proteomics of Copper Homeostasis Mutant Pedigrees.

Authors:  Stephanie A Zlatic; Alysia Vrailas-Mortimer; Avanti Gokhale; Lucas J Carey; Elizabeth Scott; Reid Burch; Morgan M McCall; Samantha Rudin-Rush; John Bowen Davis; Cortnie Hartwig; Erica Werner; Lian Li; Michael Petris; Victor Faundez
Journal:  Cell Syst       Date:  2018-01-31       Impact factor: 10.304

Review 7.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

Review 8.  Current perspective of mitochondrial biology in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Bobby Thomas
Journal:  Neurochem Int       Date:  2018-03-14       Impact factor: 3.921

9.  Chondroitin sulfate proteoglycans negatively regulate the positioning of mitochondria and endoplasmic reticulum to distal axons.

Authors:  Rajiv Sainath; Lorena Armijo-Weingart; Andrea Ketscheck; Zhuxuan Xu; Shuxin Li; Gianluca Gallo
Journal:  Dev Neurobiol       Date:  2017-09-19       Impact factor: 3.964

Review 10.  Current disease modifying approaches to treat Parkinson's disease.

Authors:  Dan Lindholm; Johanna Mäkelä; Valentina Di Liberto; Giuseppa Mudò; Natale Belluardo; Ove Eriksson; Mart Saarma
Journal:  Cell Mol Life Sci       Date:  2015-11-30       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.